drugset / Trial / NCT03323866

Mometasone vs Budesonide in CRS With Polyposis

NCT03323866

Phase 3 Terminated 36 enrolled University of Sherbrooke
RandomizedParallel-groupTriple-blindTreatment

Summary

The principal objective is to compare the use of mometasone nasal spray to budesonide irrigations in patients suffering from CRSwNP who have never been operated.

Timeline

Start
2017-05-01
Primary completion
2022-05-01
Completion
2022-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 0.5 mg/ml Intranasal
Comparator Mometasone Other / unclassified 50 ug